Earnings


  • Nick Jonas, Dexcom
    Image attribution tooltip
    Courtesy of Dexcom, Nick Jonas Super Bowl kit
    Image attribution tooltip

    Dexcom to lay off 535 employees in California

    A company spokesperson said Dexcom is centralizing its U.S. manufacturing operations in Arizona and repurposing its San Diego facility.

    By June 27, 2024
  • Intuitive Surgical's da Vinci 5 robotic system.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    New products take center stage in medtech’s latest earnings season

    From pulsed field ablation devices to Intuitive's latest da Vinci robot, product launches dominated recent earnings calls.

    By May 28, 2024
  • An image of Medtronics PulseSelect pulsed field ablation system
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic touts demand for PFA, adding to hype for the new ablation tech

    CEO Geoff Martha told investors there has already been “strong adoption” of PFA devices and the category will be a big part of Medtronic's revenue growth in fiscal year 2025.

    By May 23, 2024
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic heads into earnings having seen rivals prosper

    J.P. Morgan and RBC analysts are expecting updates on several key markets on Medtronic's Q4 call, including surgical robotics and pulsed field ablation.

    By May 21, 2024
  • An operating room has a table surrounded by screens and several overhead lights, and a surgical robot that says "Mako"
    Image attribution tooltip
    Permission granted by Stryker
    Image attribution tooltip

    Surgical robots are ‘gift that will keep on giving,’ ortho firms say

    Stryker, Zimmer and Globus reported double-digit sales growth in their robot segments and outlined plans for new products. 

    By May 9, 2024
  • A Philips factory
    Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips agrees to $1.1B settlement of US respiratory recall lawsuits

    CEO Roy Jakobs said on a first-quarter earnings call that “for the U.S., this is as final as it can get.”

    By April 29, 2024
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards gets Q1 boost as Pascal valve repair sales ramp up

    New mitral and tricuspid valve treatments are attracting strong demand, but analysts said transcatheter aortic valve replacement sales were shy of expectations.

    By April 26, 2024
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific gives first look at Farapulse US rollout

    CEO Mike Mahoney would not provide specific sales numbers for the device, but hyped the pulsed field ablation system as the “most transformational product” he’s seen in his time with the company.

    By April 24, 2024
  • A picture of the lobby of Boston Scientific's corporate China reception.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Dexcom and Edwards next as earnings season rolls on

    J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.

    By April 23, 2024
  • Intuitive Surgical's da Vinci 5 robotic system.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Intuitive’s rollout of new da Vinci 5 robot steals Q1 spotlight

    While Intuitive has already placed eight new surgical robots, executives cautioned system placements could be choppy in the coming months.

    By April 19, 2024
  • Abbott company sign outside
    Image attribution tooltip

    Courtesy of Abbott Laboratories

    Image attribution tooltip

    Abbott looks to ‘highly productive’ device pipeline for future growth

    CEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the recently approved Triclip valve a “billion-dollar opportunity."

    By April 17, 2024
  • Johnson & Johnson's new logo is seen on an office lobby wall.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    ‘We think in decades’: J&J’s $30B spending spree may not be over

    After Johnson & Johnson has doled out more than $30 billion for Abiomed, Laminar and Shockwave Medical, are more medtech deals on the way?

    By April 16, 2024
  • Vicarious Surgical plans to seek de novo clearance for its surgical robot.
    Image attribution tooltip
    Permission granted by Vicarious Surgical
    Image attribution tooltip

    Vicarious presses forward with soft tissue robot despite struggles

    The company detailed upcoming milestones for its robotic surgery system on a fourth-quarter earnings call.

    By March 6, 2024
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic estimates up to 40 job losses in Ireland due to restructuring

    The company confirmed the potential job reductions from shutting down its ventilator product lines in an email to MedTech Dive.

    By March 5, 2024
  • A brick building with a sign that says "Henry Schein Inc."
    Image attribution tooltip
    Bruce Bennett via Getty Images
    Image attribution tooltip

    Henry Schein expects cyber incident costs to continue in 2024

    The company reported a $350 million to $400 million reduction in Q4 sales due to the incident, which forced it to take some systems offline. 

    By Feb. 27, 2024
  • A surgeon holds a piece of surgical mesh for hernia and abdominal wall surgery.
    Image attribution tooltip
    Courtesy of Integra
    Image attribution tooltip

    Integra Lifesciences to cut about 60 jobs as it closes Indiana site

    Manufacturing will be transferred to a plant in Maryland as part of a strategy to bolster operational efficiency, a company spokesperson said.

    By Feb. 27, 2024
  • Thaysen is pictured in a suit and tie.
    Image attribution tooltip
    Permission granted by Illumina
    Image attribution tooltip

    Illumina cut 12% of global staff over past year: CEO

    The genomics company, which initiated a fresh round of layoffs last month, expects to finalize its Grail divestiture by the end of June, Jacob Thaysen said Thursday.

    By Feb. 9, 2024
  • Professional photo of Ivan Tornos
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer Biomet to cut about 540 jobs

    A spokesperson told MedTech Dive that the company will lay off about 3% of its workforce as part of a restructuring. 

    By Updated Feb. 8, 2024
  • A circular device with a metal mesh around it.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    How Edwards’ Evoque valve won an early nod from the FDA

    The heart valve specialist has the chance to shape a new tricuspid market with the first-of-its-kind device, like it did 20 years ago in TAVR, CEO Bernard Zovighian said.

    By Feb. 7, 2024
  • Boston Scientific's Farapulse pulsed field ablation device.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific nets Farapulse approval, pushes back US TAVR launch

    The device maker disclosed it will start the highly anticipated launch of the AFib ablation device, but approval for its aortic valve replacement implant will have to wait. 

    By Jan. 31, 2024
  • An empty hospital operating theater is prepared with lighting and equipment
    Image attribution tooltip
    JohnnyGreig via Getty Images
    Image attribution tooltip

    The top medtech trends in 2024

    Experts said M&A, orthopedic procedure backlogs and emerging cardiac markets were among the top trends to watch in the medical device industry this year.

    By MedTech Dive Staff • Jan. 31, 2024
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    What to watch for as Stryker, Boston Scientific and BD post earnings this week

    The next round of results follows reports from J&J, Abbott and Intuitive, all of which signaled a solid end to 2023.

    By Jan. 29, 2024
  • Intuitive Surgical da Vinci robot, surgeon at surgeon console
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Robot reveal: Intuitive submits 510(k) for next-generation system

    The new surgical robot will have 10,000 times the processing power of the current da Vinci model, CEO Gary Guthart said on the company’s fourth-quarter earnings call.

    By Jan. 24, 2024
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott says all four segments stronger than pre-pandemic

    CEO Robert Ford said investing in its base business using COVID-19 testing revenues was “absolutely the right strategy.”

    By Jan. 24, 2024
  • tort liability, earplugs, Aearo Technologies
    Image attribution tooltip
    "3M headquarters" by Acroterion is licensed under CC BY-SA 4.0
    Image attribution tooltip

    3M on track to complete healthcare spinoff in first half of 2024

    The healthcare leadership team will share more details as the completion of the transaction approaches.

    By Jan. 24, 2024